To a further extent, PI3K/AKT/mTOR is identified as a highly enriched pathway in translocation RCC with TFE3 fusion (TFE3-tRCC) by miRNA microarray analysis [258]. The gene discussed is PIK3CA; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.